Clinical Trial Update: Angiotensin II for Septic Shock Treatment [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Angiotensin II for septic shock was suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Septic Shock

Drugs mentioned

• Angiotensin II (angiotensin II)

Snippet

Sponsor: Cairo University | Conditions: Septic Shock | Phase 3 | Status: SUSPENDED